PMV Pharmaceuticals (PMVP) · page 7 of 19
Uses dose conversion to humans as a comparative framework to highlight potential lack of potency/viability.
Research note · villain_critique · expose_contradiction · dense density
Slide locked Sign in to view
Slide schematic 6/8
callout 0/1 chart 1/1 metric 0/1 paragraph 2/2 source-note 2/2 title 1/1
2 without position callout 1 · metric 1
calloutmetric · primary
Components 8
callout line primary paragraph paragraph source-note source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1